Santero Therapeutics
PrivateLast Round
Series A
Jun 7, 2023
Total Funding Raised
$8.56M
Momentum Score
25 /100
Company Overview
Santero Therapeutics is a biotechnology company that discovers and validates first-in-class small molecules active against life-threatening multidrug-resistant pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Santero Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Santero Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 7, 2023 |
Santero Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A |
| Newton Biocapital | Series A |
| Wallonie Entreprendre | Series A |
| Sambrinvest | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Cuong Vuong appointed as new Chief Scientific Officer.
- Feb 25, 2025
Will speak at the AMR Conference in Basel on Feb 25-26, 2025.
Santero Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Santero Therapeutics's valuation, stock price, and market status.
